Moderna, Illumina lead healthcare gains in September as medtech drags
at seekingalpha.com (Sat, 3-Oct 11:05 AM)
Leerink Partners Sticks to Their Buy Rating for Illumina (ILMN)
at www.tipranks.com (Tue, 29-Sep 8:55 AM)
